Screener
Castle Biosciences CSTL Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's free cash flow?
- Castle Biosciences (CSTL) reported free cash flow of -$34.58M in Q1 2026.
- How has Castle Biosciences's free cash flow changed year-over-year?
- Castle Biosciences's free cash flow decreased by 220.9% year-over-year, from -$10.78M to -$34.58M.
- What is the long-term trend for Castle Biosciences's free cash flow?
- Over 3 years (2021 to 2025), Castle Biosciences's free cash flow has grown at a 8.0% compound annual growth rate (CAGR), from -$22.47M to $28.33M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Castle Biosciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude